NTLA logo

Intellia Therapeutics, Inc. (NTLA) CAPEX

Annual CAPEX:

$5.78M-$8.21M(-58.68%)
December 31, 2024

Summary

  • As of today, NTLA annual capital expenditures is $5.78 million, with the most recent change of -$8.21 million (-58.68%) on December 31, 2024.
  • During the last 3 years, NTLA annual CAPEX has fallen by -$6.98 million (-54.70%).
  • NTLA annual CAPEX is now -58.68% below its all-time high of $13.98 million, reached on December 31, 2023.

Performance

NTLA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAcash flow metrics

Quarterly CAPEX:

$29.00K-$210.00K(-87.87%)
September 30, 2025

Summary

  • As of today, NTLA quarterly capital expenditures is $29.00 thousand, with the most recent change of -$210.00 thousand (-87.87%) on September 30, 2025.
  • Over the past year, NTLA quarterly CAPEX has dropped by -$1.25 million (-97.73%).
  • NTLA quarterly CAPEX is now -99.36% below its all-time high of $4.54 million, reached on September 30, 2021.

Performance

NTLA Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAcash flow metrics

TTM CAPEX:

$1.98M-$1.25M(-38.65%)
September 30, 2025

Summary

  • As of today, NTLA TTM capital expenditures is $1.98 million, with the most recent change of -$1.25 million (-38.65%) on September 30, 2025.
  • Over the past year, NTLA TTM CAPEX has dropped by -$4.33 million (-68.59%).
  • NTLA TTM CAPEX is now -87.89% below its all-time high of $16.38 million, reached on September 30, 2023.

Performance

NTLA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAcash flow metrics

NTLA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-58.7%-97.7%-68.6%
3Y3 Years-54.7%-99.3%-84.2%
5Y5 Years-14.9%-95.8%-61.5%

NTLA CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-58.7%at low-99.3%at low-87.9%at low
5Y5-Year-58.7%+61.2%-99.4%at low-87.9%at low
All-TimeAll-Time-58.7%+2001.1%-99.4%at low-87.9%+284.5%

NTLA CAPEX History

DateAnnualQuarterlyTTM
Sep 2025
-
$29.00K(-87.9%)
$1.98M(-38.7%)
Jun 2025
-
$239.00K(-67.5%)
$3.23M(-19.3%)
Mar 2025
-
$735.00K(-25.1%)
$4.01M(-30.7%)
Dec 2024
$5.78M(-58.7%)
$981.00K(-23.3%)
$5.78M(-8.5%)
Sep 2024
-
$1.28M(+26.4%)
$6.32M(-32.6%)
Jun 2024
-
$1.01M(-59.6%)
$9.37M(-26.0%)
Mar 2024
-
$2.51M(+64.9%)
$12.66M(-9.5%)
Dec 2023
$13.98M(+3.1%)
$1.52M(-64.9%)
$13.98M(-14.6%)
Sep 2023
-
$4.33M(+0.7%)
$16.38M(+0.6%)
Jun 2023
-
$4.30M(+12.2%)
$16.28M(+2.0%)
Mar 2023
-
$3.83M(-2.0%)
$15.96M(+17.7%)
Dec 2022
$13.56M(+6.3%)
$3.91M(-7.7%)
$13.56M(+8.3%)
Sep 2022
-
$4.24M(+6.5%)
$12.51M(-2.3%)
Jun 2022
-
$3.98M(+178.5%)
$12.81M(+8.9%)
Mar 2022
-
$1.43M(-50.2%)
$11.77M(-7.7%)
Dec 2021
$12.76M(+255.8%)
$2.87M(-36.8%)
$12.76M(+17.1%)
Sep 2021
-
$4.54M(+54.5%)
$10.89M(+54.4%)
Jun 2021
-
$2.94M(+21.8%)
$7.05M(+36.9%)
Mar 2021
-
$2.41M(+139.8%)
$5.15M(+43.7%)
Dec 2020
$3.58M
$1.01M(+44.1%)
$3.58M(-30.4%)
Sep 2020
-
$698.00K(-32.6%)
$5.15M(-16.9%)
Jun 2020
-
$1.04M(+22.6%)
$6.20M(+1.6%)
DateAnnualQuarterlyTTM
Mar 2020
-
$845.00K(-67.1%)
$6.11M(-10.1%)
Dec 2019
$6.79M(+6.9%)
$2.57M(+47.1%)
$6.79M(+16.9%)
Sep 2019
-
$1.75M(+85.8%)
$5.81M(-4.4%)
Jun 2019
-
$941.00K(-38.6%)
$6.08M(+0.7%)
Mar 2019
-
$1.53M(-3.7%)
$6.04M(-5.0%)
Dec 2018
$6.36M(-37.0%)
$1.59M(-21.0%)
$6.36M(-11.2%)
Sep 2018
-
$2.02M(+124.0%)
$7.16M(-3.3%)
Jun 2018
-
$900.00K(-51.4%)
$7.41M(-4.8%)
Mar 2018
-
$1.85M(-22.8%)
$7.78M(-22.9%)
Dec 2017
$10.09M(+63.7%)
$2.40M(+6.1%)
$10.09M(-9.1%)
Sep 2017
-
$2.26M(+77.7%)
$11.10M(+17.5%)
Jun 2017
-
$1.27M(-69.4%)
$9.44M(+1.3%)
Mar 2017
-
$4.16M(+22.2%)
$9.32M(+51.2%)
Dec 2016
$6.17M(+141.4%)
$3.40M(+462.8%)
$6.17M(+70.8%)
Sep 2016
-
$605.00K(-47.3%)
$3.61M(+0.1%)
Jun 2016
-
$1.15M(+13.8%)
$3.61M(+18.4%)
Mar 2016
-
$1.01M(+18.7%)
$3.05M(+19.3%)
Dec 2015
$2.55M(+828.7%)
$849.00K(+41.0%)
$2.55M(+49.8%)
Sep 2015
-
$602.00K(+2.6%)
$1.71M(+54.6%)
Jun 2015
-
$587.00K(+13.8%)
$1.10M(+113.8%)
Mar 2015
-
$516.00K
$516.00K
Dec 2014
$275.00K
-
-

FAQ

  • What is Intellia Therapeutics, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. annual CAPEX year-on-year change?
  • What is Intellia Therapeutics, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Intellia Therapeutics, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. TTM CAPEX year-on-year change?

What is Intellia Therapeutics, Inc. annual capital expenditures?

The current annual CAPEX of NTLA is $5.78M

What is the all-time high annual CAPEX for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high annual capital expenditures is $13.98M

What is Intellia Therapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, NTLA annual capital expenditures has changed by -$8.21M (-58.68%)

What is Intellia Therapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of NTLA is $29.00K

What is the all-time high quarterly CAPEX for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high quarterly capital expenditures is $4.54M

What is Intellia Therapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, NTLA quarterly capital expenditures has changed by -$1.25M (-97.73%)

What is Intellia Therapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of NTLA is $1.98M

What is the all-time high TTM CAPEX for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high TTM capital expenditures is $16.38M

What is Intellia Therapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, NTLA TTM capital expenditures has changed by -$4.33M (-68.59%)
On this page